Previous 10 | Next 10 |
2023-11-25 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-17 17:01:57 ET Gainers: Cogent Biosciences ( COGT ) +3% . Erasca ( ERAS ) +3% . Vigil Neuroscience ( VIGL ) +3% . 2seventy ( TSVT ) +2% . Twist Biosciences ( TWST ) +2% . Losers: Nkarta ( NKTX ) -5% ...
2023-11-15 13:49:41 ET More on BioMarin Pharmaceutical BioMarin: Keeping Bullish View After Q3 Earnings BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript BioMarin ...
2023-11-08 05:19:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thanks to the biotechnology sector, the advances and improvement of processes within the health sector have been incredible. The impact with society and the contribution they make both directly...
2023-11-07 14:50:25 ET More on BioMarin Pharmaceutical BioMarin: Keeping Bullish View After Q3 Earnings BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript Elliott c...
2023-11-07 10:53:35 ET More on BioMarin Pharmaceutical BioMarin: Keeping Bullish View After Q3 Earnings BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript Biggest s...
2023-11-07 09:00:56 ET More on BioMarin Pharmaceutical BioMarin: Keeping Bullish View After Q3 Earnings BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript BioMarin ...
2023-11-07 01:36:02 ET Summary BioMarin's stock has fallen over 12% in recent months, but the pullback presents an opportunity to accumulate positions. 3Q results showed lower-than-expected revenues, but adjusted EBITDA and EPS beat market expectations. Voxzogo's sales are gro...
2023-11-02 11:08:17 ET More on BioMarin Pharmaceutical BioMarin: Growth Drivers Remain Intact BioMarin appoints Alexander Hardy as president and chief executive officer BioMarin Pharmaceutical Q3 2023 Earnings Preview For further details see: BioMarin Pha...
2023-11-01 19:36:03 ET Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Conference Call November 01, 2023, 04:30 PM ET Company Participants Traci McCarty - Head of Investor Relations Jean-Jacques Bienaime - Chairman and Chief Executive Officer Jeffrey Ajer -...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-27 14:15:03 ET Scotiabank analyst issues UNDERPERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Underperform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-27 14:15:02 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Sector Perform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus...